About Chengdu Olymvax Biopharmaceuticals Inc Company

The company was founded in 2009. Since its establishment, the company has been committed to providing safe, effective and high-quality human vaccine products to domestic and foreign consumers. The company is a national high-tech enterprise focusing on R&D, production and sales of human vaccines. The main products are adsorbed tetanus vaccine, HiB conjugate vaccine, and AC conjugate vaccine. Corporate honors: The company was once again recognized as a national high-tech enterprise, and the company was awarded honors such as “2022 Sichuan New Economy Top 100 Enterprises” and “2023 Sichuan Industrial Quality Benchmark”. The company has successively won honorary titles such as “National Intellectual Property Advantage Enterprise”, “Sichuan Human Vaccine Engineering Technology Research Center”, and “Sichuan Postdoctoral Innovation Practice Base”.